An intravenous formulation of a calcitonin gene–related peptide inhibitor monoclonal antibody showed efficacy for preventing chronic migraine headaches for 3 months in a dose-ranging, phase 3 trial with 1,072 patients.
Archives
Top Posts
- New Butalbital Product(similar to Fioricet/Fiorinal/Esgic/Phrenilin)
- "What Can Cause Stomach Pain and a Headache?" from Medical News Today
- Turmeric (Curcumin) Capsules for Headaches and Arthritis Migraine blog
- CGRP QUESTIONS/ANSWERS
- Potential Link Between Cluster Headaches and Restless Legs Syndrome
- "Why Depression Symptoms Come On At Night" from The New York Times
- CGRP Migraine Monoclonal Injections: proceed with caution" from Dr. Robbins, M.D.
- Tension-Type Headache: Evidence for Trigger Points
Topics
adolescents
Alzheimer's disease
Alzheimers
anxiety
back pain
blood pressure
botox
brain
caffeine
children
chronic migraine
chronic pain
cluster headache
concussion
concussions
COVID-19
dementia
depression
diet
exercise
fibromyalgia
Headache
headache blog
headaches
health
heart disease
meditation
men
migraine
migraine headache
migraine headaches
migraines
migraine triggers
migraine with aura
pain
physical activity
sleep
stress
stroke
triggers
triptans
vitamin D
walking
women
yoga